Skip to main content

Table 1 Characteristics of the patients enrolled in the study

From: Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study

Characteristics

Number of patients

320

Female

176 (55)

Age (years)

42 [20–95]

Body weight (kg)

54.3 [26.0–101.2]

eGFR (mL/min)

75.7 [3.4–158.4]

BUN (mg/dL)

23.4 [6.2–189.8]

MgO dose (mg/day)

990 [330–2970]

Duration of MgO administration (days)

52 [1–348]

Co-administrated drugs

 PPIs

133 (46)

 H2 blocker (famotidine)

19 (6)

 VD3

23 (7)

 Diuretics

16 (5)

  1. Values are presented as median [range] or number (%)
  2. BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, MgO magnesium oxide, PPIs proton pump inhibitors, VD3 vitamin D3